Roel Meiburg

Roel Meiburg

Auto-generated profile, based on publicly available information

Roel Meiburg

Department of Biomedical Engineering Eindhoven University of Technology Eindhoven The Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
RMRoel Meiburg
Roel Meiburg
JRJesse Rijks
Jesse Rijks
ABAhmed Beela
Ahmed Beela
EBEdoardo Bressi
Edoardo Bressi
DGDomenico Grieco
Domenico Grieco
JLJoost Lumens
Joost Lumens
Aims: Focus of pacemaker therapy is shifting from right ventricular (RV) apex pacing (RVAP) and biventricular pacing (BiVP) to conduction system pacing. Direct comparison between the different pacing modalities and their consequences to cardiac pump function is difficult, due to the practical implications and confounding variables. Computational modelling and simulation provide the opportunity to compare electrical, mechanical, and haemodynamic consequences in the same virtual heart.Methods and results: Using the same single cardiac geometry, electrical activation maps following the different pacing strategies were calculated using an Eikonal model on a three-dimensional geometry, which were then used as input for a lumped mechanical and haemodynamic model (CircAdapt). We then compared simulated strain, regional myocardial work, and haemodynamic function for each pacing strategy. Selective His-bundle pacing (HBP) best replicated physiological electrical activation and led to the most homogeneous mechanical behaviour. Selective left bundle branch (LBB) pacing led to good left ventricular (LV) function but significantly increased RV load. RV activation times were reduced in non-selective LBB pacing (nsLBBP), reducing RV load but increasing heterogeneity in LV contraction. LV septal pacing led to a slower LV and more heterogeneous LV activation than nsLBBP, while RV activation was similar. BiVP led to a synchronous LV–RV, but resulted in a heterogeneous contraction. RVAP led to the slowest and most heterogeneous contraction. Haemodynamic differences were small compared to differences in local wall behaviour.Conclusion: Using a computational modelling framework, we investigated the mechanical and haemodynamic outcome of the prevailing pacing strategies in hearts with normal electrical and mechanical function. For this class of patients, nsLBBP was the best compromise between LV and RV function if HBP is not possible.

1 August 2020 in International Journal of Cardiology
Verified
Journal Article
Closed access
JZJo Zelis
Jo Zelis
RMRoel Meiburg
Roel Meiburg
JRJorn J.D. Roijen
Jorn J.D. Roijen
KJKoen L.P.M. Janssens
Koen L.P.M. Janssens
MVMarcel van 'T Veer
Marcel van 'T Veer
MRMarcel C. Rutten
Marcel C. Rutten

20 July 2020 in International Journal for Numerical Methods in Biomedical Engineering
Verified
Journal Article
Open access
PDF file
RMRoel Meiburg
Roel Meiburg
WHWouter Huberts
Wouter Huberts
MRMarcel C. M. Rutten
Marcel C. M. Rutten
FVFrans N. van de Vosse
Frans N. van de Vosse
Patient outcome in Trans‐Aortic Valve Implantation (TAVI) therapy partly relies on a patient’s haemodynamic properties that cannot be determined from current diagnostic methods alone. In this study, we predict changes in haemodynamic parameters(as apart of patient outcome) after valve replacement treatment in aortic stenosis patients. A framework to incorporate uncertainty in patient‐specific model predictions for decision support is presented. A0Dlumped parameter mode lincluding the left ventricle, astenotic valve and systemic circulatory system has been developed, based on models published earlier. The Unscented Kalman Filter (UKF)isused to optimize model input parameters to fit measured data pre‐intervention. After optimization, the valve treatment is simulated by significantly reducing valve resistance. Uncertain model parameters are then propagated using a polynomial chaos expansion approach. To test the proposed framework, three in silico test cases are developed with clinically feasible measurements. Quality and availability of simulated measured patient data are decreased in each case. The UKF approach is compared to a Monte Carlo Markov Chain (MCMC) approach, a well‐known approach in modelling predictions with uncertainty. Both methods show increased confidence intervals as measurement quality decreases. By considering three in silico test‐cases we incorporate optimization uncertainty in model predictions and is faster and the MCMC approach, although it is more sensitive to noise in flow measurements. To conclude, this work shows that the proposed framework is ready to be applied to real patient data.

31 May 2025 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
JHJohn M. Hanna
John M. Hanna
PVPavlos Varsos
Pavlos Varsos
JKJérôme Kowalski
Jérôme Kowalski
LSLorenzo Sala
Lorenzo Sala
RMRoel Meiburg
Roel Meiburg
IVIrene E. Vignon-Clementel
Irene E. Vignon-Clementel

26 February 2021 in Medical Engineering & Physics
Verified
Journal Article
Open access
RMR. Meiburg
R. Meiburg
JZJo Zelis
Jo Zelis
JVJ. Marcel van ’t Veer
J. Marcel van ’t Veer
SVSjors J.A. van Velthoven
Sjors J.A. van Velthoven
FVFrans N. van de Vosse
Frans N. van de Vosse
MRMarcel C.M. Rutten
Marcel C.M. Rutten
Current aortic stenosis severity grading is based mainly on the local properties of the stenotic valve, such as pressure gradient or jet velocity. Success rates of valve replacement therapy are still suboptimal, so alternative grading of AS should be investigated. We suggest the efficiency of power transfer from the left ventricle to the aorta, as it takes into account heart, valve and circulatory system. Left ventricular and circulatory power were estimated using a 0D model, which was optimised to patient data: left ventricular and aortic pressure, aortic flow and diastolic left ventricular volume. Optimisation was performed using a data assimilation method. These data were available in rest as well as chemically induced exercise for twelve patients. Using this limited data set, we showed that aortic valve efficiency is highly heterogeneous between patients, but also often dependent on the haemodynamic load. This indicates that power transfer efficiency is a highly interesting metric for further research in aortic stenosis.

31 March 2026 in International Journal for Numerical Methods in Biomedical Engineering
Verified
Journal Article
Open access
SVSabine Verstraeten
Sabine Verstraeten
RMRoel Meiburg
Roel Meiburg
KJKoen Janssens
Koen Janssens
MHMartijn Hoeijmakers
Martijn Hoeijmakers
NKNils Karajan
Nils Karajan
WHWouter Huberts
Wouter Huberts
Aortic stenosis (AS) severity is typically assessed by measuring pressure drop across the aortic valve in rest. However, this flow‐dependent metric is influenced by patients' cardiac function, complicating clinical decision‐making on valve replacement. Moreover, assessment during rest does not reflect valvular dynamics under higher flow rates (e.g., during exercise), and may underestimate severity in moderate AS patients. Patient‐specific Fluid–Structure Interaction (FSI) modelling offers a promising, non‐invasive method to simulate valve dynamics under varying conditions, independent of pressure exerted by the left ventricle. Therefore, this study aimed to experimentally verify an aortic stenosis FSI model using a patient‐specific aortic valve geometry, including calcifications, across flow conditions ranging from rest to exercise. To achieve this goal, in vitro experiments were conducted using a mock‐loop circulatory system with patient‐specific silicone rubber valve models, both calcified and non‐calcified. These experiments were replicated in FSI simulations. Overall, good agreement was observed between simulated and experimental results for the non‐calcified valve in terms of mean transvalvular flow (5% error on average) and aortic valve area (AVA) (10% error on average). Discrepancies were more pronounced in the calcified valve due to added complexity and uncertainty introduced by calcifications (8% and 7% error on average for mean transvalvular flow and AVA, respectively). For clinical implementation, two key challenges remain: (1) developing efficient and reliable methods to estimate valve leaflet material properties and pre‐stress, and (2) verifying the model against a broader range of in vitro data, followed by validating it against real, clinical data. Despite the remaining challenges, this study demonstrated the feasibility of using FSI models as a complementary, non‐invasive tool to assess AS severity and support clinical decision‐making on valve replacement.